Literature DB >> 3934398

The mangled extremity syndrome (M.E.S.): a severity grading system for multisystem injury of the extremity.

R T Gregory, R J Gould, M Peclet, J S Wagner, D A Gilbert, J R Wheeler, S O Snyder, R G Gayle, C W Schwab.   

Abstract

The severely mangled extremity presents a challenge in appropriate surgical management. Very few objective data were found about this problem. To clarify the situation, criteria for a "mangled extremity' were defined, a multidisciplined approach employed, and a retrospective graduated grading system developed. Sixty consecutive trauma patients with severely injured extremities during the past 3 years were reviewed. Seventeen patients fit the category of Mangled Extremity Syndrome (M.E.S.). Injuries were retrospectively classified using a graduated grading system directed at four major tissue systems of the extremity involved (integument, nerve, artery, and bone). Additional scoring items were included to define the significance of trauma sustained outside the extremities. Patients who ultimately came to amputation could have been identified preoperatively at initial emergency evaluation utilizing this graduated grading system. Retrospective data suggest that a Mangled Extremity Syndrome Index (M.E.S.I.) of 20 is the dividing line below which functional limb salvage can be expected and above which limb salvage is improbable. Prospective application of this system, as well as an organized multidisciplined approach, could be useful in the identification of functionally retrievable versus probably irretrievable extremities, thus identifying and helping define the indications for amputation. The grading system criteria and results in these 17 patients form the basis of this report.

Entities:  

Mesh:

Year:  1985        PMID: 3934398

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  19 in total

1.  Amputation and the assessment of limb viability: perceptions of two hundred and thirty two orthopaedic trainees.

Authors:  W G P Eardley; D M Taylor; P J Parker
Journal:  Ann R Coll Surg Engl       Date:  2010-05-19       Impact factor: 1.891

2.  Major limb amputations: an audit of indications in a suburban surgical practice.

Authors:  Olutola Akiode; A M Olusola Shonubi; Adewale Musa; Ganiyu Sule
Journal:  J Natl Med Assoc       Date:  2005-01       Impact factor: 1.798

3.  Soft tissue coverage of the mangled upper extremity.

Authors:  Zhi Yang Ng; Christopher J Salgado; Steven L Moran; Harvey Chim
Journal:  Semin Plast Surg       Date:  2015-02       Impact factor: 2.314

Review 4.  Current management of the mangled upper extremity.

Authors:  Marko Bumbasirevic; Milan Stevanovic; Aleksandar Lesic; Henry D E Atkinson
Journal:  Int Orthop       Date:  2012-08-25       Impact factor: 3.075

Review 5.  [Management strategies in the first operative phase after long-bone injury of the lower extremity in multiple-injured patients. A systematic literature review].

Authors:  D Rixen; S Sauerland; H-J Oestern; B Bouillon
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

6.  Limb salvage in vascular trauma of the extremities--a regional experience.

Authors:  S T O'Sullivan; D J Hehir; M O'Connor; M P Brady; J A O'Donnell
Journal:  Ir J Med Sci       Date:  1994-10       Impact factor: 1.568

7.  Management protocols in high-energy tibial fracture.

Authors:  J C Kaye
Journal:  Ann R Coll Surg Engl       Date:  1994-11       Impact factor: 1.891

8.  Management of Vascular Injuries in a Forward Hospital.

Authors:  K M Rai; S K Mohanty; R Kale; A Chakrabarty; D Prasad
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 9.  Advances in treatment of vascular injuries from blunt and penetrating limb trauma.

Authors:  R R Martin; K L Mattox; J M Burch; R J Richardson
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

10.  The utility of scores in the decision to salvage or amputation in severely injured limbs.

Authors:  Rajasekaran Shanmuganathan
Journal:  Indian J Orthop       Date:  2008-10       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.